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Purpose: Current techniques and procedures for dosimetry in microbeams typically rely on radiochro-
mic film or small volume ionization chambers for validation and quality assurance in 2D and 1D,
respectively. Whilst well characterized for clinical and preclinical radiotherapy, these methods are non-
instantaneous and do not provide real time profile information. The objective of this work is to deter-
mine the suitability of the newly developed vM1212 detector, a pixelated CMOS (complementary
metal-oxide-semiconductor) imaging sensor, for in situ and in vivo verification of x-ray microbeams.
Methods: Experiments were carried out on the vM1212 detector using a 220 kVp small animal radi-
ation research platform (SARRP) at the Helmholtz Centre Munich. A 3 x 3 cm2 square piece of
EBT3 film was placed on top of a marked nonfibrous card overlaying the sensitive silicon of the sen-
sor. One centimeter of water equivalent bolus material was placed on top of the film for build-up.
The response of the detector was compared to an Epson Expression 10000XL flatbed scanner using
FilmQA Pro with triple channel dosimetry. This was also compared to a separate exposure using
450 µm of silicon as a surrogate for the detector and a Zeiss Axio Imager 2 microscope using an
optical microscopy method of dosimetry. Microbeam collimator slits with range of nominal widths
of 25, 50, 75, and 100 µmwere used to compare beam profiles and determine sensitivity of the detec-
tor and both film measurements to different microbeams.
Results: The detector was able to measure peak and valley profiles in real-time, a significant reduction
from the 24 hr self-development required by the EBT3 film. Observed full width at half maximum
(FWHM) values were larger than the nominal slit widths, ranging from 130 to 190 µm due to divergence.
Agreement between the methods was found for peak-to-valley dose ratio (PVDR), peak to peak separation
and FWHM, but a difference in relative intensity of themicrobeams was observed between the detectors.
Conclusions: The investigation demonstrated that pixelated CMOS sensors could be applied to
microbeam radiotherapy for real-time dosimetry in the future, however the relatively large pixel pitch
of the vM1212 detector limit the immediate application of the results. © 2019 The Authors. Medical
Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Med-
icine. [https://doi.org/10.1002/mp.13971]
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Microbeam radiotherapy (MRT) is a novel type of spa-
tially fractionated therapy which is defined by narrow beams
of radiation (typically <100 µm) that can selectively irradiate
portions of the target volume.1 To cover the entire target vol-
ume, microbeams are delivered in a grid pattern in which
multiple quasi-parallel rectangular beams, with typical cen-
tre-to-centre distances of 200–400 µm. Crucially the entire
target volume is not irradiated uniformly, with regions of
very high dose microbeam "peaks" separated by very low
dose valleys.
Preclinical studies have indicated that this dose pattern has
a greater efficacy than that of a single uniform field.2 Whilst
the exact mechanism for preferential effect tumor is not fully
understood and is likely a combination of effects. Possible
mechanisms under investigation are preferential damage to
vascular tissue in tumors,3–5 and radiation-induced bystander
and abscopal effects.6,7
1.B. Current verification methods
The very small size and high dose gradients of microbe-
ams present a significant challenge to most standard detec-
tors. That combined with high dose rates at synchrotrons
adds to the complexity when working towards accurate
dosimetry for microbeam radiotherapy.
Stereotactic radiotherapy treatments (with radiation
fields sizes typically between 0.4 and 30 mm8) have strict
requirements on the geometrical and dosimetric accuracy
from dose calculations to delivery of  5% (k = 2).9
Microbeam irradiations are a step forward in terms of
complexity and at present there is no dosimetry protocol
or recommendations for dosimetry of irradiations with
such beam configurations.10
Much of the ongoing research in the community is dedi-
cated to optimizing irradiation configurations in order to
obtain the best therapeutic outcomes, with peak to peak dis-
tance,11 full-width at half maximum (FWHM)12 and the
peak-to-valley dose ratio (PVDR)13,14 being of particular
interest.
Due to the very small scales involved in microbeam radio-
therapy, conventional radiotherapy equipment for beam pro-
file acquisition (like small volume ionization chambers) are
unable to resolve the individual microbeam peaks9). Scanning
other types of small volume detectors through a microbeam
peak has been previously performed with success by using a
MOSFET dosimeter15,16 or with a commercial PTW (Physi-
kalisch-Technische Werkst€atten GmbH, Freiburg, Germany)
microdiamond detector,17 with resolutions of 1 µm.18 This
method has shown good agreement with radiochromic film,19
however the measurements are acquired point by point and
therefore the shape of the profiles are not shown instanta-
neously which limits its use for in vivo dosimetry or in situ
verification. The same applies to the use of scintillating
fibers, as shown by Archer et al.20
Various groups have developed silicon strip detectors
capable of quantifying parameters of the microbeam
field.21–23 Whilst hybrid strip detectors (with separate sen-
sor and readout) can offer greater resistance to radiation
than monolithic pixelated detectors, strip detectors do not
provide detailed information about the 2D profile of the
radiation field and, therefore, will be more sensitive to
angular misalignment.
A method of obtaining 2D relative dose distributions of
microbeams was developed by Bartzsch et al.24 using optical
microscopy and EBT3 films,25 which when using a micro-
scope is technically capable of spatial resolutions better than
1 µm. Due to film grain inhomogeneities this is reduced to
5 µm in practice. This method builds on existing techniques
for film dosimetry. Radiochromic films have a relatively large
dose range (0.1 cGy–10 Gy for EBT326), however the analy-
sis process is slow, requiring a minimum of 24 hr for self-de-
velopment post-irradiation.27 At lower dose levels (less than
0.1 Gy28,29) noise becomes more significant. This typically
necessitates two separate sets of irradiations for the same set
of microbeams, in order to be able to increase the accuracy of
the assessment of the dose distribution in the regions with
lower dose range (valleys) without saturating the high dose
region of the microbeam peaks.
This investigation was carried out to evaluate the suitabil-
ity of the newly developed vM1212 detector for its use in the
analysis of preclinical radiotherapy microbeams, using the
custom built multi-slit collimator at the Helmholtz Zentrum
M€unchen, Germany. The objective was to quantify
microbeam parameters and to compare the results of the anal-
ysis of the same deliveries to EBT3 films, using the optical
microscopy method.24
2. MATERIALS AND METHODS
2.A. vM1212 pixelated detector
The vM1212 pixelated detector is a large format CMOS
(complementary metal–oxide–semiconductor) imaging sen-
sor with 50 µm pixel pitch originally designed for medical
and scientific x-ray imaging by the CMOS Sensor Design
Group at the Rutherford Appleton Laboratory30 and is now
licensed and manufactured into a full detector assembly by
vivaMOS Ltd. The active area of the vM1212 detector is
approximately 6 9 6 cm2 (1204 9 1248 pixels) and is suffi-
ciently large to capture the entire radiation field of the
microbeam multislit collimator in a single instance.
The small pixel pitch and predicted resistance to damage
caused by high levels of ionizing radiation justified a proof of
principle investigation to determine the response of the detec-
tor to microbeam radiation.
2.B. Methodology
A SARRP (Small Animal Radiation Research Platform) x-
ray irradiator at the Helmholtz Zentrum M€unchen was used
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for this investigation. The irradiation parameters were set to
220 kVp (0.67 mm Cu HVL); 2.8 mA; and fine focus (effec-
tive beam source size of 0.4 mm31).
The tungsten microbeam multislit collimator consisted of
three levels of fifty one 100-µm slits (7 mm total thickness),
with a slit-to-slit separation of 400 µm. The first and third
levels are in a fixed alignment, whilst the second central level
is controlled by two motorized translation stages. When fully
open, the transmission gap is 100 µm, but the finest step res-
olution of the piezoelectric pistons enables variable slit
widths between 0 and 100 µm to be investigated to an accu-
racy of 0.5 µm. The collimator was mounted at a distance of
21.2 cm from the source, with additional lead shielding to
prevent radiation damage to the electronics as shown in
Fig. 1(a).
In order to obtain robust and safe positioning, the vM1212
detector had to be mounted at a source to surface distance
(SSD) of 29 cm, 6.8 cm from the surface of the microbeam
collimator. To achieve conditions similar to the ones used for
small animal irradiations a 1 cm slab of tissue-equivalent
flexible bolus material with density of 1.03 g/cm32 (trimmed
to 7 9 7 cm2) was placed on top of the EBT3 film. The
vM1212 detector was used without scintillating material to
maximize the potential spatial resolution. To enable a direct
comparison between the EBT3 film and the vM1212 detector,
EBT3 film pieces were placed on top of the active area of the
sensor, separated by a thin layer of a nonfibrous card which
had been marked for repeatable alignment [Fig. 1(b)].
The EBT3 films irradiated simultaneously to the vM1212
detector were scanned using an Epson Expression 10000XL
flatbed scanner (1400 dpi) and calibrated using FilmQA Pro
with triple channel dosimetry.33,34 Due to time constrains
during the experiment, it was not possible to irradiate a sec-
ond set of films for their analysis with optical microscopy.
Those irradiations were performed in an independent experi-
ment following the same irradiation conditions: source-sur-
face distance, same bolus material and nonfibrous card, but
using 450 µm of silicon simulating the thickness of the
detector. This second set of films was scanned using a ZEISS
Axio Imager 2 optical microscope35 on 5X magnification for
a pixel resolution of 1.29 µm.
Prior to the film irradiations, the output (Gy/min) was
measured in reference conditions for SARRP absolute cali-
bration. Measurements were performed with the SARRP
open field at Source Surface Distance (SSD) of 33 cm and at
2 cm depth in WT1 water equivalent slab phantom, with
3 cm of backscatter material. Two independent measure-
ments of the SARRP output were performed, one with the
local dosimetry system (PTW 30010 ionization chamber),
traceable to the PTW-Freiburg SSDL Calibration Laboratory
and with a National Physical Laboratory (NPL) secondary
standard system (PTW 30012 ionization chamber), traceable
to the NPL primary standard for medium energy x-rays. Both
ionization chambers used a local PTW Unidos TW1001 elec-
trometer for dosimetry. Following output measurements and
in order to obtain a calibration curve, a set of nine films were
irradiated in the same reference conditions, with doses rang-
ing from 0 to 14 Gy.
For consistency throughout the investigation, the same
integration time, 28 ms, was always used on the vM1212
detector. This ensured that all the performed measurements
were all in the linear response region for the pixels and pre-
vented saturation of the detector. The results obtained using
the vM1212 detector were corrected by averaging over a num-
ber of frames to reduce noise, subtracting a dark image to
account for dark current in the pixels and calibrating the pixel
response values against measurements with the NPL ioniza-
tion chamber under the same conditions.
Direct comparison between the EBT3 films and the differ-
ent acquisitions with vM1212 detector were carried out for
25, 50, 75, and 100 µm slit widths. All the slits were irradi-
ated with 240 s of exposure with the exception of the 25 µm
slit width which was irradiated with 480 s, to increase the
dose and therefore to reduce the level of noise for the films
measurements in such narrow beams.
Finally, to understand the difference in spatial response
between the vM1212 detector and the two methods of EBT3
film scanning, the modulation transfer function (MTF) was
measured for each. The modulation transfer function of the
vM1212 detector was measured following BS EN 62220-1-
3:200836 and using the COQ analysis software written by











FIG. 1. Experimental set up: (a) vM1212 detector with 1 cm of water equiva-
lent build-up, (b) vM1212 detector with aligned EBT3 Film. (i) Lead shield
to protect collimator electronics; (ii) Microbeam collimator; (iii) 1 cm of
water equivalent bolus; (iv) Cable for microbeam collimator; (v) vM1212
detector; (vi) Ribbon cables for vM1212 detector; (vii) Nonfibrous card with
alignment points; (viii) 3 x 3 cm2 square of EBT3 film. [Color figure can be
viewed at wileyonlinelibrary.com]
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scanner at 1400 dpi scanning resolution was measured using
a sharp flat edge positioned over a piece of unexposed EBT3
film at an angle of 4°. Again using the COQ analysis soft-
ware, the edge spread function was calculated allowing the
modulation transfer function to be determined. The MTF of
the Zeiss Axio Imager 2 was measured with the Xradia reso-
lution sample (provided by Zeiss), which contained a pattern
of lines with known width and separation. The largest line
width on this pattern was 32 µm (period = 64 µm), and as
such the smallest resolution measurable with this resolution
sample was 15.6 line pairs/mm (1/0.064 mm).
3. RESULTS
3.A. Profile measurements
It was found that the vM1212 detector was able to capture
the entire radiation field as defined by the collimator, as can
be seen in Fig. 2(b). To create the microbeam collimator slits
in tungsten, 0.3 mm diameter holes had to be drilled into the
tungsten, allowing for wire erosion to mill out the 100 µm
wide slits. This detail can be recognized on both detectors
(film and vM1212 detector) and was used for alignment pur-
poses. All profile comparisons presented are aligned relative
to the central 26th peak. By comparing vertical profiles from
the EBT3 film methods with vertical profiles taken using the
vM1212 detector we were able to observe that the alternating
pattern of peaks and valleys of the microbeam collimator are
well correlated between the different detectors. The larger
SSD required to mount the vM1212 detector and the maxi-
mum scanning size of the EBT3 film possible with the micro-
scope reduced the number of peaks that could be recorded
using this method to approximately 40 (reduced from 51
physical slits on the collimator).
The 100 µm slit profiles’ comparison can be seen in
Fig. 3(a), where an agreement in terms of alignment of the
peaks between the three detector methods can be observed.
The vM1212 detector and the Epson Expression 10000XL
under respond in terms of peak dose by approximately 30%;
however there is relatively good agreement of the location of
the microbeam peak center values [Fig. 3(b)]. As shown in
Fig. 4, relative to the Zeiss Axio Imager 2, the valley doses
are over reported by the Epson Expression 10000XL (with
scanning resolution at 1400 dpi) by approximately 25%
(15 mGy/min), whilst the vM1212 detector over reports by
less than 5% (5 mGy/min). The average deviation between
corresponding peak centers for the vM1212 detector and the
Epson Expression 10000XL measurement was 18.5 µm,
(a) (c)
(b) (d)
FIG. 2. (a) Photograph of microbeam collimator slits. (b) vM1212 detector image (cropped). (c) Scan of exposed EBT3 film using the Epson Expression
10000XL scanner (100 µm slit width). (d) Scan of exposed EBT3 film using Zeiss Axio Imager 2. [Color figure can be viewed at wileyonlinelibrary.com]
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whilst for the Zeiss Axio Imager 2 measurement was found
to be 55.3 µm. As shown in Fig. 5 for the 26th central peak,
the profile resolved on all three detector methods appears to
be Gaussian.
For the 25 µm slit width comparison (Fig. 6) the agree-
ment between the EBT3 films and the vM1212 detector
becomes worse as there is a strong disagreement for dose rate
values between the scan performed by the Zeiss Axio Imager
2 and the other methods. This deviation is likely due to spa-
tial averaging within the vM1212 detector and the Epson
Expression 10000XL, however it is also possible that this
deviation was introduced by misalignment during the Zeiss
Axio Imager 2 exposure as it was performed at a later date.
The lower measured dose rate is not consistent across the
microbeam profiles as shown for the central peak (Fig. 7),
where the dose rate measured by the vM1212 detector and
Epson Expression 10000XL EBT3 film is approximately
20% of the dose rate measured by the Zeiss Axio Imager 2.
For the Epson Expression 10000XL and the vM1212, the
dose rate measured for the 27th peak (Fig. 8) is better but still
measures only 40% relative to the Zeiss Axio Imager 2. Val-
ley profiles for the 25 µm slit measured all of the detectors
are again inconsistent, with approximate differences relative
to the Zeiss Axio Imager 2 of 40% and 20% for the vM1212
detector and Epson Expression 10000XL, respectively. This
peak specific under response not observed in the Zeiss Axio
Imager 2 measurement is suspected to be due to a combina-
tion of manufacturing tolerances on the machined microbeam
slits and repeatability issues of the microbeam setup.
Figures 7, 8 show a profile comparisons with a Gaussian
fit applied between the three detectors for the 26th (central)
FIG. 3. (a) 100 µm slit width profile comparison, (b) Microbeam peak deviation between the vM1212 detector and the two EBT3 film methods. [Color figure
can be viewed at wileyonlinelibrary.com]
FIG. 4. 100 µm slit width valley profile comparison. [Color figure can be
viewed at wileyonlinelibrary.com]
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and 27th peak, respectively. A stitching artifact between the
high dose valley irradiation and the low dose peak measure-
ment can been seen in Fig. 7 in the Zeiss Axio Imager 2 dose
profile at approximately 50 µm. The centers of the 27th
microbeam peak (relative to the 26th central peak) can be
calculated to be 550, 514, and 488 µm for the vM1212 detec-
tor, Epson Expression 10000XL and Zeiss Axio Imager 2
respectively.
The peak to peak separation could be measured across the
three detection methods for all measured slit widths, as
shown in Table I. It can be shown that the three methods
agree within the uncertainties calculated. Using the inverse
square law and the differences between the measured peak to
peak separations, it can be estimated that the EBT3 films for
the Epson Expression 10000XL and Zeiss Axio Imager 2
measurements were positioned 0.5  0.2 mm and
2.4  0.2 mm closer respectively to the x-ray source than
the vM1212 detector measurement. As the measurements for
the Epson Expression 10000XL were taken concurrently with
the vM1212 detector, this difference can be attributed to the
thickness the nonfibrous card which was independently mea-
sured with a digital caliper to be 0.53  0.01 µm. The
2.4 mm deviation of the Zeiss Axio Imager 2 measurement is
likely due to setup misalignment.
It was also found that the vM1212 detector was still able
to detect and identify each of the 51 peaks when the
microbeam collimator is fully closed (set to 0 µm slit width)
(Fig. 9). Profiles resulting from this leakage are used in Sec-
tions 3.B FWHM measurements and 3.C Peak and Valley
Measurements.
Using the vM1212 detector it is possible to take real time
horizontal profiles of the microbeam collimator. A compar-
ison between the methods averaged across all recorded peaks
for the 100 µm slit width can be seen in Fig. 10, which again
FIG. 5. 100 µm slit width profile comparison of the 26th central peak. [Color
figure can be viewed at wileyonlinelibrary.com]
FIG. 6. 25 µm slit width profile comparison. [Color figure can be viewed at wileyonlinelibrary.com]
FIG. 7. 25 µm slit width peak profile comparison of the 26th central peak.
[Color figure can be viewed at wileyonlinelibrary.com]
Medical Physics, 47 (3), March 2020
1310 Flynn et al.: Microbeam dosimetry using a CMOS sensor 1310
shows the approximately 30% under response of the vM1212
detector and Epson Expression 10000XL measurements rela-
tive to the Zeiss Axio Imager 2 measurement. The sharp ver-
tical peaks at 13,000 and 41,000 µm are due to the 0.3 mm
diameter holes seen in Fig. 2. It can be seen in all three meth-
ods that the radiation intensity does not follow a smooth pro-
file across the collimator as one might expect, although it is
beyond the scope of this paper to discuss any therapeutic
impact this may have.
3.B. FWHM measurements
An averaged FWHM comparison between the Zeiss Axio
Imager 2 and the vM1212 detector for each of the slits can be
seen in Fig. 11. The error bars shown represent one standard
deviation of uncertainty for the microbeam peaks.
A linear relationship between the FWHMs is observed;
however, there is a large deviation between FWHMs within a
measurement. This can be attributed to a significant trend in
the FWHM as a function of vertical position that was unde-
tectable at the time of the experiment that can be seen in both
the vM1212 detector results (Fig. 12) and the analyzed EBT3
films (not shown). This is most probably due to the angle of
the beam after it is produced at the tungsten target, within the
x-ray tube, known as heel effect. This effect would have
become more dominant due to the larger SSD and was not
observed on past measurements using the microbeam colli-
mator.
Such a difference in beam FWHM across the beam
profile would have had a significant impact on patient out-
come, as described by Serduc et al.12. For in vivo
FIG. 8. 25 µm slit width peak profile comparison of the 27th peak. [Color
figure can be viewed at wileyonlinelibrary.com]
TABLE I. Measured peak to peak separation as measured on the three detec-
tors. Statistical uncertainty corresponds to one standard deviation.
Nominal slit
width (µm)







25 513.4  13.9 512.0  11.3 508.3  9.9
50 512.9  10.1 511.7  9.7 508.9  9.1
75 512.6  9.2 511.9  10.1 508.3  8.6
100 512.4  9.5 511.8  9.6 508.5  9.8
FIG. 9. Radiation leakage through the collimator at 0 µm slit width as mea-
sured by the vM1212 detector. [Color figure can be viewed at wileyonlinelib
rary.com]
FIG. 10. Horizontal profile of the 100 µm slit width. [Color figure can be
viewed at wileyonlinelibrary.com]
Medical Physics, 47 (3), March 2020
1311 Flynn et al.: Microbeam dosimetry using a CMOS sensor 1311
verification this would have been impossible to diagnose
in real time with EBT3 films, due to the minimum 24 hr
time required for film self-development. This highlights a
potential application of the vM1212 detector for real time
imaging of microbeams.
A comparison of microbeam nominal slit width to the
measured FWHM can be seen in Fig. 13. As the vM1212
detector could take multiple readings with minimal dead time
between them, a repeat set of measurements was performed
to calculate the FWHM of the microbeams. Each time the slit
width was increased by 5 µm. Using this approach, it was
possible to show that below 20 µm slit width, the value of
the measured FWHM begins to increase (in relation to the
expected nominal one). This effect is well documented for
small fields in megavoltage x-ray beams38 and is due to the
finite size of the x-ray source being partially occluded by the
collimator, causing an overlapping beam penumbra. If this
geometrical penumbra is larger than the field size, then the
FWHM of the resulting beam increases. Differences between
FIG. 11. FWHM comparison between Zeiss Axio Imager 2 and the vM1212
detector. A 1:1 ratio has been added to guide the eye. [Color figure can be
viewed at wileyonlinelibrary.com]
FIG. 12. FWHM trend as measured by the vM1212 detector. [Color figure
can be viewed at wileyonlinelibrary.com]
FIG. 13. Comparing the microbeam slit width to observed FWHM. [Color
figure can be viewed at wileyonlinelibrary.com]
FIG. 14. Geometric setup of the microbeam collimator, resulting in the larger
full width at half maximum (FWHM). [Color figure can be viewed at wileyon
linelibrary.com]
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the two vM1212 detector measurements are attributed to sub-
tle differences when repositioning the detector and uncertain-
ties in the reproducibility of the collimator movements,
however this effect appears to be minimal.
The larger FWHM for all measurements can be attributed
to the finite size of the x-ray source. As shown in Fig. 14, for
a finite source size (S), collimator slit width (w), source-colli-
mator distance (A), and collimator-projection distance (B);








For this approximation and to simplify the scatter effects,
we assumed that the collimator is infinitely thin and consists
of only one layer instead of the three that comprise the
actual and previously described design of the collimator.
With the previous assumptions we are considering the calcu-
lated projected beam size as an approximation of the
FWHM of the microbeam peak. Using the values described
previously for A, B and S, the values for the theoretical
resolvable slit size were plotted on Fig. 13 for comparison
with measured results. With Eq. (1), the smallest microbeam
peak FWHM created by the collimator that could be possi-
ble to resolve would be equal to 128.3  13.0 µm (assum-
ing 10% uncertainty of x-ray source size), whilst using the
extrapolated results from the vM1212 detector the minimum
is calculated to be 126.0  0.7 µm. The differences in the
slope between the derived (geometric approximation) and
measured (vM1212 detector repeat linear fit) FWHMs are
likely to be due to the numerous approximations and would
need full Monte Carlo simulation with an accurate model of
the geometry and scatter conditions.
3.C. Peak and Valley Measurements
By fitting Gaussians to each of the peaks in both the
vM1212 detector and EBT3 film profiles, the Peak-to-Valley
Dose Ratio (PVDR) can be estimated and compared to results
reported in the literature (Fig. 15). The values calculated for the
PVDR were comparable to what one might expect for this
microbeam collimator when comparing to previous measure-
ments in a similar collimator by Bartzsch et al. (where
15.5  1.5 was measured at 10 mm depth),39 especially when
considering the significantly larger SSD of this investigation.
The PVDRs obtained using the Epson Expression 10000XL
for the 25 and 50 µm slit widths were found to be significantly
larger than both predicted by literature and as reported by the
vM1212 detector and the Zeiss Axio Imager 2 measurements.
This can be attributed to a significant under response of the
Epson Expression 10000XL to the microbeam valleys, as shown
in Fig. 16. It is possible that the two film method used for optical
microscopy could be applied to compensate for this and record
a more accurate dose profile; however this was not within the
scope of the investigation.
Using the vM1212 detector it was possible to rapidly cal-
culate the PVDR for a large number of slit widths. As shown
in Fig. 9, radiation leak is present through the collimator at
slit width 0 µm from which a PVDR could be calculated.
The decrease in PVDR below 20 µm is consistent with the
increase in FWHM as observed in Fig. 13 which was attribu-
ted to an increased proportion of the radiation resulting from
scatter with decreasing slit width.
3.D. Modulation transfer measurements
The results of modulation transfer measurements are
shown in Fig. 17. It can be shown that while the spatial
FIG. 15. Comparison of PVDR for different slit widths. The PVDR measure-
ments for the 25 and 50 µm slit width Epson Expression 10000XL are omit-
ted. [Color figure can be viewed at wileyonlinelibrary.com]
FIG. 16. 25 µm slit width valley profile comparison. [Color figure can be
viewed at wileyonlinelibrary.com]
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resolution of the vM1212 detector is better than the Epson
Expression 10000XL scanner, the Zeiss Axio Imager 2
microscope is superior to both.
4. DISCUSSION
In comparison to dedicated facilities such as the European
Synchrotron Radiation Facility (ESRF), the x-ray source used
for this investigation was not optimized for microbeam radio-
therapy with the dose rate measured after the collimator to be
less than 0.05 Gy/s. This is substantially less than the dose
rate used at synchrotrons for microbeam radiotherapy (often
exceeding 100 Gy/s).40 The microbeam FWHMs delivered in
this investigation are significantly larger than the 25 µm wide
beams capable at the ESRF and as such, further research of
the vM1212 detector under such beam conditions is required.
The mean energy of this investigation (approximately 95 keV
as calculated by the x-ray emission spectra calculation soft-
ware SpekCalc41–43) was comparable to that of dedicated
synchrotrons,44,45 however undoubtedly the effect of the dif-
ferent spectra must be considered.
A comparison of the three microbeam detection methods
evaluated in this work can be seen in Table II. Whilst the
vM1212 detector has demonstrated the feasibility of a CMOS
sensor for microbeams measurement in this investigation, sig-
nificant deviations to established dosimetry methods were
observed and further studies comparing to Monte Carlo simu-
lations for relative dosimetry are still necessary. The Zeiss
Axio Imager 2 remains a suitable readout method for com-
missioning and situations where maximum precision is
required however, this method is relatively young and vali-
dated protocols and workflows need to be established to
allow wider uptake for this method among microbeam com-
munity. The use of the Epson Expression 10000XL for
microbeam measurements is not recommended due to the
(relatively) poor spatial resolution.
The vM1212 detector does not possess the spatial resolu-
tion necessary for accurate microbeam dosimetry with its rel-
atively large 50 µm pixels, compared to other quality
assurance mechanisms discussed previously (such as the
PTW microdiamond) with ~1 µm resolution. In addition,
well established characteristics of other detection methods
necessary for routine quality assurance such as dose rate and
beam quality dependence have not been taken into account.
The vM1212 detector operates using a "rolling shutter" frame
acquisition method which does not present an issue for static
or slow moving microbeam sources such as the type used in
this investigation but may not be ideal for fast scanned
microbeam spots. Additionally the maximum full field
refresh rate of 34 fps may cause temporal blurring, however
this effect could be minimized by binning pixels together or
recording only a smaller region of interest. This refresh rate
is still considerably lower than that of commercial radiother-
apy electrometers (such as the Unidos webline with 1 kHz
sampling rate46). Whilst the dose delivered to the films
scanned by the Epson Expression 10000XL is relatively low
(average peak dose of >1 Gy) for EBT3 film standards, it
must be noted that the vM1212 detector is capable of
FIG. 17. Comparison of MTF for different measurement techniques. [Color
figure can be viewed at wileyonlinelibrary.com]
TABLE II. Comparison of the different microbeam detection methods evaluated in this work.
Microbeam detection method
vM1212 detector Zeiss Axio Imager 2 (+ EBT3 film) Epson Expression 10000XL (+ EBT3 film)
Advantages Real time measurement and analysisShort
exposure is sufficient to obtain accurate profile
information
Highest spatial resolutionNo dose
rate dependence49
Lower costEstablished clinical workflowNo dose
rate dependence49
Disadvantages Limited life expectancy due to cumulative
radiation damageSpatial resolution limited by
50 µm pixel pitch
24 hours self-developmentComplex
and time consuming analysis process
24 hours self-developmentPoorest spatial
resolution ad hence limited suitability for
microbeam applications
Higher price Necessity to establish procedures and
workflow for wider uptake of this
method
Software licensing costs
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obtaining similar or better quality images in less than 2 mGy
per frame, highlighting its potential for real-time microbeam
verification.
Looking forward, CMOS sensors resistant to ionizing
radiation have been developed for other harsh radiation envi-
ronments (such as space), achieving pixel pitches of less than
10 µm47,48 in size. The use of such sensors in the future could
obtain real-time microbeam profile information surpassing
even that of the Zeiss Axio Imager 2, however making these
sensors large enough to cover the same field of view as the
vM1212 detector could become prohibitively expensive due
the number of pixels required and sensor yield losses.
5. CONCLUSION
Microbeam radiotherapy is a rapidly developing method
of cancer treatment with significant therapeutic improve-
ments over conventional radiotherapy.50,51 The dosimetric
challenges associated with the high dose gradients in
microbeam radiotherapy prevent the use of well-established
dosimetry equipment used in radiotherapy and (to date), all
novel techniques for monitoring microbeams have only
obtained one dimensional profile information; limiting their
clinical viability.
In this study, we have demonstrated the capacity of the two
dimensional vM1212 pixelated detector to discriminate indi-
vidual microbeams peaks with FWHM between 130 and
190 µm. The high dynamic range of the vM1212 detector
allows the signal detection of both the high dose peaks and the
low dose valleys (of microbeams with less than 20 PVDR) to
be measured in real-time, which provides a significant advan-
tage over EBT3 films requiring at least 24 hr post-irradiation
processing. Observed peak-to-valley dose ratios and peak to
peak separations measured by the vM1212 detector were com-
parable those obtained using the optical microscopy method
employing Zeiss Axio Imager 2 microscope. The use of pixe-
lated sensors for in-vivo beam monitoring in conventional
radiotherapy beams is already being researched by multiple
groups52,53 and as the technology behind the sensors matures,
it is anticipated that future CMOS detectors will have all of the
required characteristics for microbeam dosimetry.
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